| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |